Jakob Sons, co-founder and managing director of the Cansativa Group, is the strategic mind and legal expert behind the Cansativa Group. Together with his brother Benedikt, he has built Cansativa into the leading platform in the German medical cannabis sector. As a German lawyer, who studied at the Universities of Heidelberg and Würzburg, he brings years of experience from international law firms. Jakob is an expert when it comes to technological, regulatory, and entrepreneurial issues. Since 2017, Cansativa has developed into a "One-Stop-Shop" with the broadest and most diverse brand portfolio in the German market.

Benedikt Sons is the co-founder, CEO, and managing director of the Cansativa Group – the market leader in the German medical cannabis market. Together with his brother Jakob, he turned Cansativa from a vision into a leading platform, known as a “One-Stop-Shop” for the most comprehensive multi-brand portfolio in Germany. Benedikt studied industrial engineering at the Karlsruhe Institute of Technology (KIT) and the University of California San Diego (UCSD). With his experience in strategy development and scaling new business models, he is the driving force of innovation behind Cansativa, pushing the company to set new standards in the industry.

Our Special Guest Berner is a true visionary, blending the worlds of music, fashion, and cannabis in an impressive way. As a successful entrepreneur and innovator, he has built a globally recognized brand in the cannabis industry, making waves not just in the U.S., but internationally as well. With over 70 locations in six countries and a growing fanbase, his company is considered a leader in the industry.

Prof. Dr. med. Kirsten R Müller-Vahl is a specialist in neurology and psychiatry and a senior physician at the Clinic for Psychiatry, Social Psychiatry, and Psychotherapy at the Hannover Medical School (MHH). She is the Chairwoman of the "Association for Cannabis as Medicine" and the "International Association for Cannabis as Medicine" (IACM), as well as a member of the Expert Committee on Narcotic Drugs of the Federal Opium Agency at the Federal Institute for Drugs and Medical Devices (BfArM). She serves as an editor or member of the editorial board for the journals "Cannabis and Cannabinoid Research" and "Medical Cannabis and Cannabinoids."

Finn Age Hänsel is the founder and CEO of Sanity Group. Previously, he was CEO of Movinga and a consultant at Boston Consulting Group. In Australia, he helped build THE ICONIC and Hello Fresh for Rocket Internet and later led ProSiebenSat.1's incubator, EPIC Companies. In 2015, the Flensburg native co-founded the craft beer brewery Berliner Berg. Hänsel serves on the board of the German Startup Association, is a mentor at Techstars, and has been a member of the Advisory Board for Young Digital Economy at the Federal Ministry for Economic Affairs since 2020. He has been advocating for cannabis legalization within the CDU since 2002.

Gero Kohlhaas (1979) is a cannabis patient and spokesperson for the Cannabis Self-Help Network (CSN). Formerly employed in the social and education sector, he is now self-employed as a consultant and speaker. As someone who understands the challenges faced by patients who supply themselves, Gero advocates for free access to cannabis and low-threshold therapy options.

Bertan Türemis is a neurobiologist and Medical Science Liaison Manager at Fette Pharma. He is deeply involved in medical cannabis research and translates scientific findings into an understandable format. On LinkedIn, he regularly publishes short videos summarizing research results for professionals. His focus is on informing both experts and the public about the current state and applications of medical cannabis. He places great importance on evidence-based information and aims to make scientific advancements comprehensible and accessible.

Melanie Dolfen is a pharmacist, entrepreneur, and one of the leading pioneers in medical cannabis provision in Germany. Since 2013, she has been managing one of the first pharmacies to dispense medical cannabis through special exemptions. With her years of experience, she has played a key role in enabling patients to access this alternative therapy and in sustainably improving care. In addition to her work in medical cannabis, she operates another pharmacy in Berlin that specializes in sexual health and advances innovative care concepts in this field.

Yordanka Caglar has been a pharmaceutical and commercial employee at the Tiergarten pharmacy in Constance since 2008. As an expert in cannabis medication, she clarifies important patient questions on cost coverage, variety selection and the use of medicinal cannabis products. Thanks to her many years of experience in the practical use and procurement of medicinal cannabis, coupled with her in-depth knowledge of quality and therapeutic applications, she is able to provide us with valuable insights.

Bijan has worked for Canopy Growth and Khiron Life Sciences in the past and now consults cannabis businesses on market entry and commercial strategy. As a certified pharmaceutical consultant he has had countless interactions with physicians, pharmacists and patients and now focuses on leveraging education and data analytics to increase access to cannabinoid medicines. BCH Consulting works across a number of industries including Pharma, Cannabis, Health Tech, FMCG and more.